Incidence and risk factors for development of hepatocellular carcinoma at young age in patients with chronic hepatitis B

被引:7
|
作者
Goh, Myung Ji [1 ]
Kang, Wonseok [1 ,2 ,3 ]
Kim, Kwang Min [4 ]
Sinn, Dong Hyun [1 ]
Gwak, Geum-Youn [1 ]
Paik, Yong-Han [1 ]
Choi, Moon Seok [1 ]
Lee, Joon Hyeok [1 ]
Koh, Kwang Cheol [1 ]
Paik, Seung Woon [1 ]
机构
[1] Sungkyunkwan Univ, Samsung Med Ctr, Dept Med, Sch Med, 81 Irwon Ro, Seoul 06351, South Korea
[2] Sungkyunkwan Univ, Samsung Adv Inst Hlth Sci & Technol SAIHST, Dept Hlth Sci & Technol, Seoul, South Korea
[3] Samsung Med Ctr, Res Inst Future Med, Seoul, South Korea
[4] Sungkyunkwan Univ, Samsung Changwon Hosp, Dept Med, Sch Med, Chang Won, South Korea
基金
新加坡国家研究基金会;
关键词
Hepatocellular carcinoma; surveillance; FIB-4; young; chronic hepatitis B; INDEX; PROGNOSIS; FEATURES; FIBROSIS; CANCER;
D O I
10.1080/00365521.2021.1988700
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Background Some young adults with chronic hepatitis B virus (HBV) infection might be at high risk for hepatocellular carcinoma (HCC), enough to justify regular HCC surveillance despite the young age of the patients. However, ways to identify at-risk individuals who may benefit from HCC surveillance need further evaluations. Methods A hospital-based retrospective cohort of 2757 chronic HBV mono-infected young adults (median age: 34 years, males 66%) were analyzed. The primary outcome was young-onset HCC, defined as a diagnosis made under 40 years of age. We calculated the HCC incidence/1000 person-years in the overall cohort and pre-defined subgroups of patients assessed the independent risk factors that can be used to identify surveillance targets. Results The HCC incidence was low (2.55/1000 person-years) in the overall cohort. However, the HCC incidence varied widely according to baseline characteristics: lowest among young adults with FIB-4 <= 0.70 (0.17/1000 person-years) and highest in young adults with radiological cirrhosis (30.7/1000 person-years). In multivariable analysis, radiological cirrhosis, the FIB-4 index, and serum HBV DNA level were independent factors associated with HCC development at a young age. Performance for prediction of young-onset HCC in radiological cirrhotic patients showed the highest specificity but sensitivity was Conclusion Risk stratification using FIB-4 index, HBV DNA levels, and either combining radiological cirrhosis or gender and AFP levels would be helpful to stratify young patients who would and would not benefit from regular HCC surveillance.
引用
收藏
页码:70 / 77
页数:8
相关论文
共 50 条
  • [1] Risk Factors for Hepatocellular Carcinoma in Cirrhotic Patients with Chronic Hepatitis B
    Zhang, Yuan-Qing
    Peng, Li-Jun
    Cao, Yi-Rong
    Zeng, Zhi-Ping
    Wu, Yu-Jing
    Shi, Hong
    Cheng, Shi-Yao
    Wang, Ji-Yao
    Friedman, Scott L.
    Sninsky, John J.
    Guo, Jin-Sheng
    GENETIC TESTING AND MOLECULAR BIOMARKERS, 2016, 20 (09) : 535 - 543
  • [2] RISK FACTORS FOR THE DEVELOPMENT OF HEPATOCELLULAR CARCINOMA AFTER ANTIVIRAL THERAPY FOR CHRONIC HEPATITIS B PATIENTS
    Chen, Junjie
    Feng, Tienan
    Zhang, Xinxin
    HEPATOLOGY, 2023, 78 : S491 - S492
  • [3] A Study for the Risk Factors of Hepatocellular Carcinoma in Cirrhotic Patients with Chronic Hepatitis B
    Zhang, Yuanqing
    Peng, Lijun
    Cao, Yirong
    Zeng, Zhiping
    Wu, Yujing
    Shi, Hong
    Chen, Shiyao
    Wang, Jiyao
    Friedman, Scott L.
    Sninsky, John J.
    Guo, Jinsheng
    HEPATOLOGY, 2015, 62 : 275A - 276A
  • [4] Independent risk factors and predictive score for the development of hepatocellular carcinoma in chronic hepatitis B
    Yuen, M. F.
    Tanaka, Y.
    Fong, D. Y.
    Fung, J.
    Wong, D. K.
    Yuen, J. C.
    But, D. Y.
    Chan, A. O.
    Wong, B. C.
    Mizokami, M.
    Lai, C. L.
    JOURNAL OF HEPATOLOGY, 2008, 48 : S252 - S252
  • [5] Independent risk factors and predictive score for the development of hepatocellular carcinoma in chronic hepatitis B
    Yuen, Man-Fung
    Tanaka, Yasuhito
    Fong, Daniel Yee-Tak
    Fung, James
    Wong, Danny Ka-Ho
    Yuen, John Chi-Hang
    But, David Ylu-Kuen
    Chan, Annie On-On
    Wong, Benjamin Chun-Yu
    Mjzokami, Masashi
    Lai, Ching-Lung
    JOURNAL OF HEPATOLOGY, 2009, 50 (01) : 80 - 88
  • [6] Incidence and Risk Factors for Hepatocellular Carcinoma in Patients with Chronic Hepatitis C after the Eradication of HCV
    Toyoda, Hidenori
    Kumada, Takashi
    Tada, Toshifumi
    Ito, Takanori
    HEPATOLOGY, 2013, 58 : 1168A - 1168A
  • [7] Risk factors for hepatocellular carcinoma in patients with drug-resistant chronic hepatitis B
    Chung Hwan Jun
    Hyoung Ju Hong
    Min Woo Chung
    Seon Young Park
    Sung Bum Cho
    Chang Hwan Park
    Young Eun Joo
    Hyun Soo Kim
    Sung Kyu Choi
    Jong Sun Rew
    World Journal of Gastroenterology, 2013, (40) : 6834 - 6841
  • [8] Risk factors for hepatocellular carcinoma in patients with drug-resistant chronic hepatitis B
    Jun, Chung Hwan
    Hong, Hyoung Ju
    Chung, Min Woo
    Park, Seon Young
    Cho, Sung Bum
    Park, Chang Hwan
    Joo, Young Eun
    Kim, Hyun Soo
    Choi, Sung Kyu
    Rew, Jong Sun
    WORLD JOURNAL OF GASTROENTEROLOGY, 2013, 19 (40) : 6834 - 6841
  • [9] RISK FACTORS FOR HEPATOCELLULAR CARCINOMA AMONG PATIENTS WITH CHRONIC HEPATITIS B TREATED WITH ENTECAVIR
    Yamada, R.
    Hiramatsu, N.
    Morishita, N.
    Harada, N.
    Oze, T.
    Yakushijin, T.
    Miyagi, T.
    Yoshida, Y.
    Tatsumi, T.
    Ohkawa, K.
    Kasahara, A.
    Mita, E.
    Hagiwara, H.
    Oshita, M.
    Itoh, T.
    Hijioka, T.
    Yoshihara, H.
    Imai, Y.
    Hayashi, N.
    Takehara, T.
    JOURNAL OF HEPATOLOGY, 2014, 60 (01) : S425 - S425
  • [10] Entecavir reduces the incidence of hepatocellular carcinoma in patients with chronic hepatitis B
    Yasunaka, Tetsuya
    Ikeda, Fusao
    Takaki, Akinobu
    Seno, Tomonori
    Takaguchi, Koichi
    Yamamoto, Kazuhide
    HEPATOLOGY, 2014, 60 : 1096A - 1096A